Results 101 to 110 of about 18,791 (142)

A Clinical Trial of FK506 in Refractory Uveitis

American Journal of Ophthalmology, 1993
We performed a clinical open trial to evaluate the efficacy and the adverse side effects of a single therapy with FK506 in refractory uveitis as a multicenter study in Japan. Fifty-three patients (41 patients with Bechçet's disease, five with Vogt-Koyanagi-Harada disease, four with idiopathic retinal vasculitis, and three with other forms of uveitis ...
Manabu Mochizuki, Kanjiro Masuda, Tsuyoshi Sakane, Koji Ito, Mitsuko Kogure, Nobuhiro Sugino, Masahiko Usui, Yutaka Mizushima, Shigeaki Ohno, Goro Inaba, Yoshitaka Miyanaga, Seiji Hayasaka, Kotaro Oizumi   +12 more
openaire   +2 more sources

The Effect Of Fk506 On Canine Bile Flow

Transplantation, 1993
While the primary immunosuppressive agents utilized in solid-organ transplantation are steroids and cyclosporine, the more recently introduced agent FK506 is assuming a progressively more important role as an immunosuppressant, particularly in liver transplantation.
J C, Reese, R B, Fairchild, H, Solomon, V, Warty, D L, Kaminski   +4 more
openaire   +2 more sources

Comparative efficacy of liposomal FK506 with FK506

Transplantation Proceedings, 1998
S D, Moffatt, V, McAlister, R Y, Calne, S, Metcalfe   +3 more
openaire   +2 more sources

Overview of FK506 in transplantation.

Clinical transplants, 1991
FK506 is a potent immunosuppressive agent which is undergoing clinical testing in liver, kidney, heart, and bone marrow transplantation. It has been shown to effectively prevent and reverse ongoing rejection in these models. From the outset, FK506 was used with low-dose steroids to treat 110 primary liver, 30 heart, and 66 kidney graft recipients ...
Fung, JJ, Abu-Elmagd, K, Todo, S, Shapiro, R, Tzakis, A, Jordan, M, Armitage, J, Jain, A, Alessiani, M, Martin, M   +9 more
openaire   +1 more source

FK506

Transplantation, 1992
openaire   +2 more sources

Development of a macromolecular prodrug of FK506: I. synthesis of FK506-dextran conjugate

Transplantation Proceedings, 1998
H, Yura, N, Yoshimura, T, Hamashima, T, Oka, Y, Takakura, M, Hashida   +5 more
openaire   +2 more sources

Microneedle-mediated transdermal delivery of FK506 for treatment of acute cardiac allograft rejection

Materials and Design, 2023
Qiaofeng Jin, , Chenyuan Wang
exaly  

Stability of FK506 in Blood Samples

Therapeutic Drug Monitoring, 1996
A M, Alak, P, Lizak
openaire   +2 more sources

Delivery of FK506-loaded PLGA nanoparticles prolongs cardiac allograft survival

International Journal of Pharmaceutics, 2020
, Qing Lv, Qiaofeng Jin
exaly  

Preformulation of FK506 Prodrugs for Improving Solubility

Bulletin of the Korean Chemical Society, 2016
Sung-Joo Hwang, Cheong-Weon Cho, Sang-Hun Jung   +2 more
exaly